EUVIMEDEUVIMED entdecken
Open Access

First-in-human study of an optimized, potential kit-type, SSTR antagonist 68 Ga-DATA 5m -LM4 in patients with metastatic neuroendocrine tumors

Jingjing Zhang, Lukas Greifenstein, Vivianne Jakobsson, Elcin Zan, Andre Klega, Frank Rösch, Christian Landvogt, Corinna Mueller, Richard P Baum

Theranostics · 2025

DOI: 10.7150/thno.94521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Jingjing Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Receptors, Somatostatin, Gallium Radioisotopes, Radiopharmaceuticals. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsReceptors, SomatostatinGallium RadioisotopesRadiopharmaceuticalsHumansMaleFemaleMiddle AgedAgedPositron Emission Tomography Computed TomographyTissue DistributionAdultNeoplasm Metastasis

Stichwörter der Autor:innen

68Ga-DATA5m-LM4PET/CTSSTR antagonistfirst-in-humanneuroendocrine tumors (NETs)somatostatin receptor

Substanzen

Receptors, SomatostatinGallium RadioisotopesRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Theranostics Center of Excellence, Yong Loo Lin School of Medicine, National University of Singapore, 11 Biopolis Way, Helios, Singapore 138667, Singapore.
  • Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Curanosticum Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Wiesbaden, Germany.
  • Academy for Precision Oncology, International Centers for Precision Oncology (ICPO), Wiesbaden, Germany.

Zitieren

APA

Zhang, J., Greifenstein, L., Jakobsson, V., Zan, E., Klega, A., Rösch, F., Landvogt, C., Mueller, C., & Baum, R. P. (2025). First-in-human study of an optimized, potential kit-type, SSTR antagonist 68 Ga-DATA 5m -LM4 in patients with metastatic neuroendocrine tumors. Theranostics. https://doi.org/10.7150/thno.94521

Vancouver

Zhang J, Greifenstein L, Jakobsson V, Zan E, Klega A, Rösch F, et al. First-in-human study of an optimized, potential kit-type, SSTR antagonist 68 Ga-DATA 5m -LM4 in patients with metastatic neuroendocrine tumors. Theranostics. 2025. doi:10.7150/thno.94521

BibTeX
@article{Zhang2025,
  author = {Zhang, Jingjing and Greifenstein, Lukas and Jakobsson, Vivianne and Zan, Elcin and Klega, Andre and Rösch, Frank and Landvogt, Christian and Mueller, Corinna and Baum, Richard P},
  title = {First-in-human study of an optimized, potential kit-type, SSTR antagonist 68 Ga-DATA 5m -LM4 in patients with metastatic neuroendocrine tumors},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.94521}
}
Kostenlos starten →